REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
30/08/2025
Voltar para busca
Dado oficial do USPTO
GENEA BIOMEDX GEMS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
31/08/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5
Data de depósito
12/06/2015
Data de registro
30/08/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/09/2023
Última transação
31/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
Sydney NSW, AU
Examinador
MITTLER,ROBIN M
Unidade examinadora
N10
Localização atual
GENERIC WEB UPDATE
Descrição da marca
The mark consists of a square divided by a curved line, next to the stylized wording "GENEA BIOMEDX", which is above the larger stylized wording "GEMS".
Titulares e representantes
Titulares
Genea IP Holdings Pty Ltd
Genea IP Holdings Pty Ltd
Representantes
Eric Lamb Frost Brown Todd LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Cell culture media other than for medical or veterinary usefor laboratory use in relation to researchingdiagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilisationdivision and cultivation; cell culture media other than for medical or veterinary usefor scientific and research use in relation to researchingdiagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilisationdivision and cultivation; human cell productspluripotent and differentiated human cells and stem cells for research or scientific purposes; human cell productspluripotent and differentiated human cells and stem cells for laboratory use excluding medical and veterinary use; biological and chemical products and substances for scientific use other than for medical or veterinary usechemicals for use in science in relation to researchingdiagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilisationdivision and cultivationchemical preparations for scientific purposes in relation to researchingdiagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilisationdivision and cultivationbiological preparations to support growth of human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocyteschemical preparations to support growth of human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocyteschemical reagents for scientific use in relation to researchingdiagnosing and/or treating fertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilisationdivision and cultivation
Classe 5
Culture media for medical use for use to support growth of human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytes for medical purposes; cell culture media for medical use for use to support growth of human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytes for medical purposes; human cell productspluripotent and differentiated human cells and stem cells for medical or clinical use; cell culture media for use in medical or medical research applications for cultivating human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytes; biological and chemical products and substances for medical use excluding dietary supplementsnutritional supplementsvaccines and antibioticschemicals for medical or clinical use in relation to assisted reproductive therapiescell fertilisationcell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and reproductionchemical preparations for medical or clinical use in relation to assisted reproductive therapiescell fertilisationcell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and human reproductionchemical preparations for the treatment of infertility and other disorders relating to fertility and human reproductionbiological preparations for the treatment of infertility and other disorders relating to fertility and human reproductionbiological preparations to support growth of human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocyteschemical preparations to support growth of human cellshuman embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocyteschemical reagents for medical use in relation to assisted reproductive therapiescell fertilisationcell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and reproduction; pharmaceutical preparations for the treatment of infertility and other disorders relating to fertility and human reproductionexcluding dietary supplementsnutritional supplementsvaccines and antibiotics
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/07/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/09/2023
71AG
REGISTERED-SEC.71 ACCEPTED
08/09/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/09/2023
ES71
TEAS SECTION 71 RECEIVED
20/02/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/01/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
30/08/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/02/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/01/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/02/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/02/2017
FIMP
FINAL DISPOSITION PROCESSED
01/02/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/11/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
30/08/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
22/07/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/07/2016
PUBO
PUBLISHED FOR OPPOSITION
14/06/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/06/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/06/2016
NPUB
NOTICE OF PUBLICATION
25/05/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/05/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/04/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/04/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/04/2016
RFNT
REFUSAL PROCESSED BY IB
24/10/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/10/2015
RFRR
REFUSAL PROCESSED BY MPU
08/10/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/10/2015
CNRT
NON-FINAL ACTION WRITTEN
06/10/2015
DOCK
ASSIGNED TO EXAMINER
22/09/2015
MAFR
APPLICATION FILING RECEIPT MAILED
08/09/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/09/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/08/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GENEA BIOMEDX GEMS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.